Roy Strowd to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Roy Strowd has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.982
-
Strowd RE, Abuali I, Ye X, Lu Y, Grossman SA. The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide. J Neurooncol. 2016 Mar; 127(1):165-71.
Score: 0.432
-
Strowd RE, Holdhoff M, Grossman SA. Chemotherapy for treatment of grade II gliomas. Oncology (Williston Park). 2014 Dec; 28(12):1036-43.
Score: 0.400
-
Doheny D, Sirkisoon S, Carpenter RL, Aguayo NR, Regua AT, Anguelov M, Manore SG, Arrigo A, Jalboush SA, Wong GL, Yu Y, Wagner CJ, Chan M, Ruiz J, Thomas A, Strowd R, Lin J, Lo HW. Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis. Oncogene. 2020 10; 39(42):6589-6605.
Score: 0.149